Density-dependent growth inhibition of fibroblasts ectopically expressing p27(kip1)

Molecular Biology of the Cell

Volumn 11, Issue 6, 2000, Pages 2117-2130

  Zhang, Xiaohong ^a   Wharton, Walker ^a   Donovan, Marcia ^a   Coppola, Domenico ^a,b   Croxton, Rhonda ^a   Cress, W Douglas ^a   Pledger, W J ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P27; ROSCOVITINE;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL DENSITY; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; GROWTH INHIBITION; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTION;

ANIMALIA; TUMOR VIRUS;

EID: 0034081919     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.11.6.2117     Document Type: Article

References (65)

1. kip1 during mitosis in BALB/ c-3T3 cells. Cell Growth Differ. 6, 1199-1205.
2. kip1 synthesis by platelet-derived growth factor in BALB/c-3T3 cells. Mol. Cell. Biol. 16, 4327-4336.
3. Kip1. EMBO J. 37, 5987-5997.
4. Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J. Biol. Chem. 272, 25863-25872.
5. Chellappan, S., Kraus, V.B., Kroger, B., Munger, K., Howley, P.M., Phelps, W.C., and Nevins, J.R. (1992). Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA 89, 4549-4553.
6. Chellappan, S.P., Hiebert, S., Mudryj, M., Horowitz, J.M., and Nevins, J.R. (1991). The E2F transcription factor is a cellular target for the RB protein. Cell 65, 1053-1061.
7. Kip1 CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18, 1571-1583.
8. Kip1 for restriction point control of the fibroblast cell cycle. Science 272, 877-880.
9. Kip1-deficient cells. Curr. Biol. 9, 163-173.
10. 1/S-regulatory genes. Mol. Cell. Biol. 15, 4215-4224.
11. kip1 in BALB/c-3T3 cells. Mol. Biol. Cell 9, 2081-2092.
12. Dong, F., Cress, W.D., Jr., Agrawal, D., and Pledger, W.J. (1998b). The role of cyclin D3-dependent kinase in the phosphorylation of p130 in mouse BALB/c-3T3 fibroblasts. J. Biol. Chem. 273, 6190-6195.
13. Ewen, M.E., Sluss, H.K., Sherr, C.J., Matsushime, H., Kato, J., and Livingston, D.M. (1993). Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73, 487-497.
14. Kip1-deficient mice. Cell 85, 733-744.
15. Flores, A.M., Kassatly, R.F., and Cress, W.D. (1998). E2F-3 accumulation is regulated by polypeptide stability. Oncogene 16, 1289-1298.
16. 1 cycling in the functional inactivation of the retinoblastoma protein. Genes Dev. 8, 1759-1771.
17. Hauser, P.J., Agrawal, D., Chu, B., and Pledger, W.J. (1997) p107 and p130 associated cyclin A has altered substrate specificity. J. Biol. Chem. 272, 22954-22959.
18. Kip1 accumulation during the cell cycle. Science 271, 1861-1864.
19. Hinds, P.W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S.I., and Weinberg, R.A. (1992). Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70, 993-1006.
20. 1 exit. Genes Dev. 10, 851-861.
21. Kato, J., Matsushime, H., Hiebert, S.W., Ewen, M.E., and Sherr, C.J. (1993). Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7, 331-342.
22. Kip1) of cyclin-dependent kinase 4 activation. Cell 79, 487-496.
23. Kip1. Cell 85, 721-732.
24. Labow, M.A., Baim, S.B., Shenk, T., and Levine, A.J. (1990). Conversion of the lac repressor into an allosterically regulated transcriptional activator for mammalian cells. Mol. Cell. Biol. 10, 3343-3356.
25. Lavoie, J.N., Rivard, N., L'Allemain G., and Pouyssegur, J. (1996). A temporal and biochemical link between growth factor-activated MAP kinases, cyclin D1 induction and cell cycle entry. Prog, Cell Cycle Res. 2, 29-58.
26. Levine, A.J. (1990). Tumor suppressor genes. Bioessays 12, 60-66.
27. Lundberg, A.S., and Weinberg, R.A. (1998). Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18, 753-761.
28. Luo, R.X., Postigo, A.A., and Dean, D.C. (1998). Rb interacts with histone deacetylase to repress transcription. Cell 92, 463-473.
29. 1 cyclins. Cell 71, 323-334.
30. Matsushime, H., Quelle, D.E., Shurtleff, S.A., Shibuya, M., Sherr, C.J., and Kato, J.Y. (1994). D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14, 2066-2076.
31. 1 phase of the cell cycle. Cell 65, 701-713.
32. Meijer, L., Borgne, A., Mulner, O., Chong, J.P., Blow, J.J., Inagaki, N., Inagaki, M., Delcros, J.G., and Moulinoux, J.P. (1997). Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243, 527-536.
33. Kip1 mRNA is a mechanism contributing to accumulation during growth arrest. J. Biol. Chem. 272, 7093-7098.
34. Mudryj, M., Devoto, S.H., Hiebert, S.W., Hunter, T., Pines, J., and Nevins, J.R. (1991). Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Cell 65, 1243-1253.
35. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85, 707-720.
36. Nevins, J.R. (1998). Towards an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9, 585-593.
37. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372, 570-573.
38. 1 in mammalian fibroblasts. Science 259, 1908-1912.
39. Pagano, M., Tam, S.W., Theodoras, A.M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P.R., Draetta, G.F., and Rolfe, M. (1995). Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269, 682-685.
40. Pestov, D.G., and Lau, L.F. (1994). Genetic selection of growth-inhibitory sequences in mammalian cells. Proc. Natl. Acad. Sci. USA 91, 12549-12553.
41. Planas-Silva, M.D., and Weinberg, R.A. (1997). The restriction point and control of cell proliferation. Curr. Opin. Cell Biol. 9, 768-772.
42. kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22.
43. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66.
44. Poon, R.Y., Toyoshima, H., and Hunter, T. (1995). Redistribution of the CDK inhibitor p27 between different cyclin-CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol. Biol. Cell 6, 1197-1213.
45. 1-to-S transition. Mol. Cell. Biol. 15, 3463-3469.
46. 0 state) in fibroblasts. J. Biol. Chem. 271, 18337-18341.
47. Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382, 325-331.
48. Schulze, A., Zerfass, K., Spitkovsky, D., Middendorp, S., Berges, J., Helin, K., Jansen-Durr, P., and Henglein, B. (1995). Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc. Natl. Acad. Sci. USA 92, 11264-11268.
49. Sherr, C.J. (1996). Cancer cell cycles. Science 274, 1672-1677.
50. 1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163.
51. 1-phase progression. Genes Dev. 13, 1501-1512.
52. kip1 induces an accumulation of the repressor complexes of E2F and inhibits expression of the E2F-regulated genes. Mol. Biol. Cell 8, 1815-1827.
53. Slingerland, J.M., Hengst, L., Pan, C.H., Alexander, D., Stampfer, M.R., and Reed, S.I. (1994). A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol. Cell. Biol. 14, 3683-3694.
54. 1 cell state. Mol. Cell. Biol. 16, 6965-6976.
55. Solomon, M.J., Harper, J.W., and Shuttleworth, J. (1993). CAK, the p34cdc2 activating kinase, contains a protein identical or closely related to p40MO15. EMBO J. 12, 3133-3142.
56. St. Croix, B., and Kerbel, R.S. (1997). Cell adhesion and drug resistance in cancer. Curr. Opin. Oncol. 9, 549-556.
57. Tassan, J.P., Schultz, S.J., Bartek, J., and Nigg, E.A. (1994). Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase). J. Cell Biol. 127, 467-478.
58. Kip1 is instigated by Jab1. Nature 398, 160-165.
59. 1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67-74.
60. Kip1 is localized to the cytosol in Swiss/3T3 cells. Oncogene 18, 5204-5210.
61. Weintraub, S.J., Chow, K.N., Luo, R.X., Zhang, S.H., He, S., and Dean, D.C. (1995). Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375, 812-815.
62. Weintraub, S.J., Prater, C.A., and Dean, D.C. (1992). Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358, 259-261.
63. Winston, J.T., Coats, S.R., Wang, Y.Z., and Pledger, W.J. (1996a). Regulation of the cell cycle machinery by oncogenic ras. Oncogene 12, 127-134.
64. kip1 by platelet-derived growth factor and plasma factors in density-arrested fibroblasts. J. Biol. Chem. 271, 11253-11260.
65. Winston, J.T., and Pledger, W.J. (1993). Growth factor regulation of cyclin D1 mRNA expression through protein synthesis-dependent and -independent mechanisms. Mol. Biol. Cell 4, 1133-1144.